Announcements Trials
Browse Landscape

Phase

Phase 2 79Phase 3 35Phase 1 23Phase 1/2 21Phase NA 6Phase 2/3 4Phase EARLY_PHASE1 2Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma, Large B-Cell, Diffuse 2Prostatic Neoplasms 1Plasmablastic Lymphoma 1Lymphoma, T-Cell, Peripheral 1Leukemia, Large Granular Lymphocytic 1Advanced B-cell Lymphoid Malignancies 1

Interventions

Cyclophosphamide 4Rituximab 3Vincristine 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Immunotherapy, Adoptive 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Doxorubicin 2tisagenlecleucel 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1oblimersen 1ibritumomab tiuxetan 1duvelisib 1Surveys and Questionnaires 1Sugars 1Specimen Handling 1Radiation 1Pemetrexed 1Nivolumab 1NVP-BKM120 1Microarray Analysis 1Methotrexate 1Loratadine 1Leukapheresis 1Immunohistochemistry 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma, Large B-Cell, Diffuse × Prednisone × Clear all
NCT01760226 2025-10-14

DA-EPOCH-R

Baylor College of Medicine

Phase EARLY_PHASE1 Completed
4 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00736450 2023-10-24

Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

University of Nebraska

Phase EARLY_PHASE1 Terminated
37 enrolled 8 charts
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡